# GLP-1 Weight Loss Drugs: The science vs. the marketing with Dr. Rebecka Peebles and Nathalia Trees, RD

Page: https://stenobird.com/podcast/feisty-women-s-performance-3663324/glp-1-weight-loss-drugs-the-science-vs-the-marketing-with-dr-rebecka-peebles-and-nathalia-trees-rd
Text version: https://stenobird.com/podcast/feisty-women-s-performance-3663324/glp-1-weight-loss-drugs-the-science-vs-the-marketing-with-dr-rebecka-peebles-and-nathalia-trees-rd.md
Podcast: [Feisty Women's Performance](https://stenobird.com/podcast/feisty-women-s-performance-3663324)
Published: 2026-05-25T08:00:00+00:00
Episode link: https://livefeisty.com/category/podcasts/feisty-womens-performance-podcast/
Audio file: https://pdst.fm/e/pscrb.fm/rss/p/pdcn.co/e/episodes.captivate.fm/episode/ab2653a4-a522-4e94-9a18-dd8ae4ae853a.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/feisty-women-s-performance-3663324/episodes/glp-1-weight-loss-drugs-the-science-vs-the-marketing-with-dr-rebecka-peebles-and-nathalia-trees-rd
Duration seconds: 3864

## Resource

Dr. Rebecka Peebles and registered dietitian Nathalia Trees dive into the booming world GLP-1 medications and the complex intersection of weight loss, body size, eating disorders, and marketing. They unpack the rapid rise of these weight loss drugs, the scientific and ethical dilemmas for clinicians, and practical strategies for navigating weight loss treatments. Whether you're on GLP-1s right now or considering the pros and cons of the medications, this episode will give you a clearer understanding of the risks, benefits, and long‑term considerations of these drugs. Key Takeaways Prescriptions for GLP‑1 drugs have surged since 2023, especially for adolescents, but long‑term safety data at high doses remains limited. Clinicians have to weigh metabolic benefits for diabetes against potential harm for patients with eating‑disorder histories. Transparent communication about side‑effects—GI issues, rare ocular events, and possible mood changes—is critical. Sustainable weight management, including the popular "microdosing" of GLP-1s, requires a holistic approach. Dr. Rebecka Peebles – VP of Adolescent Medicine at Monte Nido, obesity‑medicine certified, expert in GLP‑1 therapy and its application to youth. Nathalia Trees – Registered dietitian at Monte Nido, specialist in eating‑disorder treatment, weight‑inclusive care, and nutrition‑focused performance coaching. Links & Resources Guest email contacts: rpeebles@montenido.com | ntrees@montenido.com FDA’s warning letter to Novo Nordisk Journal of Fat Studies article exposing GLP‑1 trial data gaps If you found this conversation insightful, hit Subscribe so you never miss an episode, leave a 5‑star review to help other professionals discover the show, and join the discussion on social media with Feisty Women’s Perofrmance.…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/feisty-women-s-performance-3663324/episodes/glp-1-weight-loss-drugs-the-science-vs-the-marketing-with-dr-rebecka-peebles-and-nathalia-trees-rd/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/feisty-women-s-performance-3663324/glp-1-weight-loss-drugs-the-science-vs-the-marketing-with-dr-rebecka-peebles-and-nathalia-trees-rd.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.